Recombinant humanized anti-rabies monoclonal antibody(Lanzhou Institute Of Biological )
重组人源抗狂犬病毒单抗（兰州生物）
Report date: 2026/03/04 20:01:44
Base Information
Drug NameRecombinant humanized anti-rabies monoclonal antibody(Lanzhou Institute Of Biological )
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLanzhou Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesLanzhou Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A